Loxo Oncology is dedicated to developing highly selective medicines for patients with genetically defined cancers. The Company bases its approach on two scientific trends: the increasing use of genetic testing in cancer clinical medicine and improving chemistry approaches to building highly selective inhibitors against single targets in the cancer cell. Loxo Oncology is developing a pipeline of highly selective drugs that inhibit oncogenic drivers in cancer.
|Size (employees)||47 (est)+57%|
Net income (Q2, 2018)
EBIT (Q2, 2018)
Market capitalization (4-Dec-2018)
Closing stock price (4-Dec-2018)
|USD||Q2, 2015||Q3, 2015||Q1, 2016||Q2, 2016||Q3, 2016||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018|
General and administrative expense
Operating expense total
|USD||Q3, 2014||Q2, 2015||Q3, 2015||Q3, 2016||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018|
|USD||Q3, 2014||Q1, 2015||Q2, 2015||Q3, 2015||Q1, 2016||Q2, 2016||Q3, 2016||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018|
Depreciation and Amortization
Cash From Operating Activities
When was Loxo Oncology founded?
Loxo Oncology was founded in 2013.
How many employees does Loxo Oncology have?
Loxo Oncology has 47 employees.
Who are Loxo Oncology competitors?
Competitors of Loxo Oncology include Keryx Biopharmaceuticals, NovaBay Pharmaceuticals and Chiasma.
Where is Loxo Oncology headquarters?
Loxo Oncology headquarters is located at 281 Tresser Blvd, Stamford.
Where are Loxo Oncology offices?
Loxo Oncology has offices in Stamford and South San Francisco.
How many offices does Loxo Oncology have?
Loxo Oncology has 2 offices.